VS-prostac
VS-prostac, licence 80073409: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Vancouver Sunshine Prostac
- Licence holder
- Vancouver Sunshine Life Tech Group LLP
- NPN or DIN-HM
- 80073409
- Status
- Active licence
- Licence date
- 1 November 2016
- Revision date
- 21 September 2017
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Epimedium brevicornu Source : Feuille Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 500 milligramme | 50.0 milligramme | Not calculated |
| Serenoa repens Source : Serenoa repens - fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 500 milligramme | 50.0 milligramme | Not calculated |
| Lycopène Source : Lycopène | 3.0 milligramme | Not calculated |
| Lycopène Source : Citrus aurantium - fruit | 3.0 milligramme | Not calculated |
| Lycium barbarum Source : Fruit Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 250 milligramme | 50.0 milligramme | Not calculated |
| Oxyde de zinc Source : Oxyde de zinc | 15.0 milligramme | Not calculated |
| Sélénium Source : Saccharomyces cerevisiae - en entier | 50.0 microgrammes | Not calculated |
| Sélénium Source : Sélénium | 50.0 microgrammes | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium, Graine de citrouille
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 1.0 Capsule | 3.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in herbal medicine to relieve symptoms of medically diagnosed mild to moderate benign prostatic hypertrophy including frequent day and night urination, difficulty in starting and finishing urination and a weak urinary flow.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80073409
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.